Navigation Links
Global Veterinary Vaccines Industry
Date:7/3/2012

NEW YORK, July 3, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Global Veterinary Vaccines Industry

http://www.reportlinker.com/p092485/Global-Veterinary-Vaccines-Industry.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_

This report analyzes the worldwide markets for Veterinary Vaccines in US$ Million by the following Product Segments - Companion Animal Vaccines (Canine Vaccines, & Feline Vaccines), and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines, & Other Animal Vaccines). The report provides separate comprehensive analytics for the US, Europe, and Rest of World. Annual estimates and forecasts are provided for each region for the period 2009 through 2017. A six-year historic analysis is also provided for these markets. The report profiles 69 companies including many key and niche players such as Bayer HealthCare AG, Biogenesis-Bago, Boehringer Ingelheim GmbH, Heska Corporation, Imugene Limited, Indian Immunologicals Ltd., Lohmann Animal Health, Merck & Co., Inc., Merck Animal Health, Merial Ltd., Pfizer, Inc., Pfizer Animal Health Global Poultry, Fort Dodge Animal Health, Protein Sciences Corporation, and Virbac Corporation. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based upon search engine sources in the public domain.

 

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations I-1

Disclaimers I-2

Data Interpretation & Reporting Level I-3

Quantitative Techniques & Analytics I-3

Product Definitions and Scope of Study I-3

A. Companion Animal Vaccines I-4

B. Livestock Vaccines I-4

Porcine Vaccines I-4

Bovine Vaccines I-4

Poultry Vaccines I-4

Ovine Vaccines I-4

Equine Vaccines I-5

Other Animal Vaccines I-5

 

II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW & OUTLOOK II-1

Global Animal Health Care Industry - A Brief Review II-1

Table 1: Global Animal Health Products Market by Region

(2011): Percentage Share Breakdown by Value Sales for North

America, Europe, Latin America and Rest of World (includes

corresponding Graph/Chart) II-1

 

Table 2: Global Animal Health Products Market by Product

Group (2011): Percentage Share Breakdown by Value sales for

Parasiticides, Vaccines, Anti-Infectives, Medical Feed

Additives and Other Pharmaceuticals (includes corresponding

Graph/Chart) II-1

Animal Healthcare Market Grows Amidst Recession II-2

Veterinary Vaccines Industry Posts Moderate Growth II-2

Poultry Vaccines Industry: A Global Scenario II-2

Improved Manufacturing Techniques II-3

Improved Analysis II-3

Scope of the Report II-3

 

2. MARKET TRENDS & ISSUES II-4

Companion Animal Vaccines: Trailing on a High Growth Track II-4

OTC Market: A Potential Threat for Veterinarians II-4

Small Animal Practitioners Feel the Pinch of Recession II-4

Parasiticides, Systemic Agents To Drive The Market II-4

Taxonomy of Vaccines II-4

Bird Flu - The Aftermath II-5

Vaccination - Critical for Controlling Avian Influenza Virus II-5

 

3. PRODUCT OVERVIEW II-6

Vaccines - An Evolutionary Scan II-6

Contribution of Animal Research to Vaccine Production II-6

Veterinary Medicines- A Brief Review II-7

Preventive Medicines II-7

Therapeutic Medicines II-7

Others II-7

Development of Vaccines II-7

Production of Vaccines II-8

Veterinary Vaccines - An Essential Component of Animal Health

Care II-8

What Does A Veterinary Vaccine Do? II-9

Classification of Veterinary Vaccines II-9

Companion Animals Vaccines II-9

Canine Vaccines II-9

Feline Vaccines II-11

Livestock Vaccines II-12

Bovine Vaccines II-12

Poultry Vaccines II-13

Ovine Vaccines II-13

Porcine Vaccines II-14

Equine Vaccines II-14

Aquaculture Vaccines II-14

A Tabular Analysis on Select Animal Diseases Controlled by

Vaccines II-15

Vaccination and Its Reactions II-15

Veterinary Vaccines- Latest Breakthroughs II-15

Marker vaccines II-15

DNA vaccines II-15

Gene-deleted vaccines II-16

Viral-vectored vaccines II-16

 

4. NOTES ON SELECT ANIMAL DISEASES II-17

Brucellosis II-17

Tuberculosis II-17

Johne's disease II-17

Spirochete Associated Diseases II-17

Respiratory Disease in Goats, Sheep, and Cattle II-18

Porcine Respiratory Diseases II-18

Mastitis II-18

African Swine Fever II-18

Avian Influenza II-19

East Coast Fever II-19

Hemorrhagic Septicemia II-19

Foot-And-Mouth Disease II-19

Japanese Encephalitis II-19

Rift Valley Fever II-20

Equine Virus II-20

 

5. PRODUCT INNOVATIONS/INTRODUCTIONS II-21

Intervet/Schering-Plough Animal Health Introduces a New Web

Site for Innovax recombinant Vaccines Product Line II-21

Pfizer Animal Health Introduces the First E. Coli Bacterial

Extract Vaccine II-21

Intervet Schering-Plough Animal Health Re-Launches EQUILIS®

StrepE for Horses II-21

Boehringer Ingelheim Vetmedica Launches Single Shot 3FLEX

combination package PL II-21

Pfizer Animal Health Launches INFORCE™ 3 II-21

Boehringer Ingelheim Introduces Ingelvac CircoFLEX® in Russia II-22

Pfizer Animal Health Introduces Bopriva® for Bull and Beef

Market in NZ II-22

GALVmed, Inter-African Bureau for Animal Resources Launch ECF

Vaccine II-22

BIVI launches Five New Variants of Vetera® Vaccines II-23

Hipra Announces Launch of Suiseng® II-23

Aceto Corporation Receives Approval to Sell Suppliera[euro]™

in the US II-23

Intervet Schering-Plough Unleashes NOBIVAC Lyme Vaccine for Dogs II-24

Intervet Schering-Plough Animal Health Introduces PORCILIS PCV

Vaccine II-24

Lohmann Launches AviPro® MEGAN®VAC Vaccination for Salmonella

Disease II-24

Intervet Schering Plough Animal Health Introduces Circovirosis

Vaccine II-24

Pfizer Animal Health Develops Inovocox® Vaccine II-24

Intervet/Schering-Plough Animal Health Launches Bravoxin 10 II-25

Bioject and Merial Rolls Out Derma-Vac NF II-25

Defra to Launch Bovine Tuberculosis Vaccine II-25

 

6. PRODUCT INTRODUCTIONS/INNOVATIONS - A HISTORIC PERSPECTIVE BUILDER II-26

Intervet International Develops Bluetongue Vaccine II-26

Hester Biosciences Unveils Anti-Coryza Vaccine II-26

Intervet/Schering-Plough Animal Health Introduces Bovilis BTV8

Vaccine II-26

Tecnovax Develops Vaccine for Salmon Virus II-26

Tamil Nadu Veterinary and Animal Science University and The

Indian Veterinary Research Institute Develop Vaccine II-26

Lohmann Animal Health Develops AviPro IBD Xtreme II-26

Intervet/Schering-Plough Animal Health Launches EquiRab™ II-27

Lohmann Animal Health Introduces Larger Doses of AviPro®

ViBursa CE II-27

Lohmann Animal Health International Rolls Out AviBlue II-27

Fort Dodge Animal Health Unveils West Nile-Innovator DNA II-28

Univet Agricultural Products Introduces Coglapest II-28

Intervet/Schering-Plough Animal Health Launches Porcilis® COLI 6C II-28

Pfizer Animal Health Unveils FluSure® XP Defense System II-28

Pfizer Animal Health Launches Improvac® II-29

Intervet/Schering-Plough Animal Health Develops Onset™ 5

Intranasal (IN) Vaccine II-29

Merial Rolls Out BTVPUR AlSap 8 II-29

Pfizer Animal Health Introduces FarrowSure® GOLD and

FarrowSure® GOLD B II-30

Schering-Plough Animal Health Unveils CAVALRY 9 II-30

Lohmann Animal Health Develops BTO2 REO Vaccine II-30

Agroinsuvet Introduces New Vaccines II-31

Merial Rolls Out Vaxxitek® HVT+IBD Hatchery Vaccine for

Poultry Industry II-31

Intervet & Friedrich-Loeffler-Institute Develop Dual Vaccine

Prototype for Birds II-31

Schering-Plough Receives USDA License for its Rhusigen™

Erysipelas Vaccine II-31

USDA Approves Use of PreveNile™ Vaccine for Horses II-32

Fort Dodge Animal Health Develops Reverse Genetics Avian Vaccine II-32

Boehringer Ingelheim's Swine Vaccine Gains Approval in Australia II-32

Merial Limited Gets USDA Approval for DNA Vaccine for Melanoma

in Dogs II-32

Embrex's Poultry Vaccine Inovocox Gets USDA Approval II-33

Skystar Bio-Pharmaceutical Develops Avian Influenza Vaccine II-33

United States Department of Agriculture Grants Conditional

License for Necrotic Enteritis Vaccine II-33

Fort Dodge Receives USDA License for Pyramid®10 II-33

USDA Licenses Use of Fort Dodge's Suvaxyn® PCV2 Vaccine in Pigs II-34

USDA Grants Conditional License to Pfizer's New Canine Vaccine II-34

 

7. RECENT INDUSTRY ACTIVITY II-35

Pfizer to Restructure Indian Animal Health Unit II-35

Pfizer Poultry Health Acquires Alpharma II-35

Intervet/Schering-Plough Animal Health Becomes Merck Animal

Health II-35

Centegen Enters into Licensing Partnership with Merial II-35

The Ugandan Government Enters into Partnership with Brentec

Vaccines International II-36

Pfizer Animal Health Kicks Off Equine Business Unit II-36

Pfizer Animal Health Acquires Microtek II-36

GenVec Enters into Collaboration with Merial to Develop and

Commercialize FMD Vaccine II-36

Pfizer Animal Health Inks Global Licensing Deal with Epitopix II-37

Indian Immunologicals Intends to Establish a New Facility in

Hyderabad II-37

Pfizer Phases out Animal Vaccine Manufacturing Unit of Wyeth

in the Netherlands II-37

Vivalis Signs Commercial License for EB66® Cell Line Platform II-37

Ibio Grants Rights of iBioLaunch platform to Government Funded

Project II-37

Intervet/Schering-Plough Animal Health Unveils Production

Center at Boxmeer II-38

Globion India Announced Plans to Develop Eight New Vaccines II-38

Veterinary Services Department Intends to Upgrade VRI II-38

VIVALIS Grants Rights of EB66® Cell Line To KYOTO BIKEN II-38

Vical Enters Into Agreement with GenomIdea for Development of

DNA Vaccine II-38

Intervet/Schering-Plough Animal Health Unveils the New Freeze

-drying and Specialized Central Filling Unit II-39

Him Electronics Enters into Partnership with Hester Bioscience

to Produce Animal Vaccines II-39

Intervet/Schering-Plough Animal Health Receives Approval for

Nobivac Lepto4 II-40

Biolex Enters into Collaboration With Merial for Research and

Development II-40

Intervet/Schering-Plough Animal Health Receives Full License

from USDA for Nobivac® Vaccine II-40

Intercell Inks License Agreement with Boehringer II-41

Intervet/Schering-Plough Recalls PreveNile West Nile Virus

Vaccine in the US II-41

Merial Gains Full License of ONCEPT™ from USDA II-41

Virbac Acquires Veterinary Assets from Pfizer II-41

Harbin Pharmaceutical Group Holding Acquires Animal Vaccine

Business From Pfizer II-41

Boehringer Ingelheim Acquires Certain Cattle Vaccines from

Fort Dodge II-41

Virbac Acquires 30% Share in Santa Elena II-42

Merck and Sanofi-Aventis to Merge their Animal Health Business II-42

Elanco to Take Over Pfizer's Animal Health Products Portfolio II-42

Boehringer Ingelhei to Acquire Pfizer's Fort Dodge Animal

Health Unit II-42

ImmunoVaccine Inks Deal with Pfizer II-43

Merck Merges with Schering-Plough II-43

Pfizer Acquires Wyeth II-43

Merial Receives Marketing License for BTVPUR AlSap 8 Vaccine II-44

Epitopix Obtains Approval to Sell Siderophore Receptor and

Porin Vaccine II-44

Phibro Animal Health Acquires Animal Health Division of Abic II-44

Fort Dodge Animal Health and Vivalis Sign Commercial License Deal II-45

Hester Biosciences Expands Gujarat Based Facility II-45

Intervet/Schering-Plough Animal Health Replaces Bovilis® IBR

Vaccine with Bovilis® IBR Marker Live II-45

Tangshan Yian Biological Engineering Wins Approval from

Ministry of Agriculture of China II-45

Lohmann Animal Health International Signs an Agreement with

Celldex Therapeutics II-46

Intervet/Schering-Plough Animal Health Starts New

Manufacturing Facility II-46

Laprovet Commences New Facility II-46

ImmunoVaccine Technologies and La Jolla Institute for Allergy

& Immunology Enter into an Agreement II-46

Merial Signs a Toll Distribution and Manufacturing Agreement

with Newport Laboratories II-47

BOEHRINGER INGELHEIM Animal Health Signs Research License Deal

with Vivalis II-47

AviTech Selects Merial as a Distributor and Service Provider II-47

 

8. STRATEGIC CORPORATE DEVELOPMENTS - A HISTORIC PERSPECTIVE BUILDER II-48

Bayer Inks Agreement with Juvaris II-48

Pfizer Inks Agreement with ImmunoVaccine Technologies II-48

BioVet Inaugurates BSL-4 Production Unit in India II-48

Vaxine to Take over Protein Sciences II-48

Pfizer Inaugurates a New Development Facility for Veterinary

Vaccines II-48

Merial to Establish Animal Vaccine Manufacturing Plant II-49

BNC Bioniche Life Sciences Bags Approval to Sell Econiche

Vaccines II-49

Hind Bio-Pharmaceuticals to Establish Animal Vaccines Division II-49

Pfizer's Animal Health Unit Acquires Schering-Plough's Product

License in Europe II-49

Grupo Mathiesen Takes Over Centro de Diagnostico Veterinario II-50

Harbin Veterinary Research Institute Opens Animal Vaccine

Manufacturing Base II-50

Bioject Medical Technologies Enters into a Long-Term Supply,

Development and License Contract with Merial II-50

Vivalis SA Signs Letter of Intent with Intervet/ Schering-Plough II-50

Biochemiq Enters into Partnership with Labovet II-51

Microbix Biosystems Purchases Production Plant II-51

Beijing Veterinary Biological Product Factory Starts Operation

in New Plant II-51

Changzhou Tongtai Biopharmaceutical Sets Up Rabies Vaccine

Facility II-51

Schering-Plough to Sell Health Products of Animals to Pfizer

and Virbac II-51

Pfizer Group Establishes a Veterinary Vaccines Development Center II-52

Phylaxia to Acquire Gazdasagi Radio and Kozep-europai

Gazterminal Zrt II-52

Bayer HealthCare AG's Animal Health Unit Enters into Licensing

Agreement with Juvaris BioTherapeutics II-52

Vivalis Enters into a Commercial License Contract with Virbac II-52

ImmunoVaccine Technologies Signs Licensing Agreement with

Pfizer Animal Health II-52

Kaketsuken and Vivalis Extends Research Collaboration II-53

Heska Amends Distribution Contract with Agri Laboratories II-53

Prevtec Microbia and Saskatchewan Research Council Receives

Approval to Market and Manufacture Coliprotec II-53

Imugene and Merial Enter into an Agreement II-53

Celldex Therapeutics Merges with AVANT Immunotherapeutics'

Subsidiary II-54

Ceva Sante Animale Acquires Delvet II-54

Inovio Biomedical Signs Merger Agreement with VGX Pharmaceuticals II-54

Environmental Risk Management Authority Approves equine

Influenza Vaccine II-54

Functional Technologies Commences Operations of Phyterra Bio II-55

Summit VetPharm Enters into Distribution Partnership with

Webster Veterinary Unit II-55

PerOs Receives Establishment and Bacterin License from USDA II-55

Wyeth's Fort Dodge Animal Health Unit Acquires Poultry Vaccines II-55

Boehringer Ingelheim Vetmedica Receives Approval for Express®

FP and Express® Vaccines from the USDA II-56

Merial Bags Major Australian Contract II-56

United States Department of Agriculture Approves Intervet Vaccine II-56

Merial Pockets Ancare II-56

Heska Revises Distribution Agreement with AgriLabs II-57

Animal Health International Acquires Kane Veterinary Supplies II-57

Industrial Equity Investments Pockets Arysta LifeScience II-57

Henry Schein Acquires W&J Dunlop II-57

Tecnovax Establishes New Facility II-57

Pingtung Agricultural to Set Up an Exclusive Veterinary Park II-58

Ouro Fino To Expand Veterinary Product Suite II-58

Alpharma Acquires Yantai Jinhai II-58

Pfizer Animal Health Acquires Embrex II-58

Schering-Plough Acquires Intervet II-58

Schering-Plough Acquires Organon BioSciences II-59

Intervet Sets Up New Animal Vaccine Production Facility in

Boxmeer II-59

Crucell Licenses PER.C6® Technology to Pfizer Animal Health II-59

Central Veterinary Research Laboratory to Synthesize New

Animal Vaccines II-59

Pfizer to Shut Down Omaha Animal Vaccine Center II-60

IGI Licenses Novasomes to Novavax II-60

Bogor Agricultural Institute Collaborates with Shigeta Animal

Pharmaceuticals II-60

Suguna Poultry Steps into Livestock Vaccine Production Business II-61

European Medicines Agency Grants Community Authorization for

Nobilis Influenza H7N1 II-61

AVANT Immunotherapeutics & Pfizer Collaborate to Develop

Animal Vaccines II-61

Intervet International Acquires FMD Vaccine Production

Facility from Bayer Healthcare II-61

Canadian Food Inspection Agency Authorizes Bioniche E. Coli

O157:H7 Cattle Vaccine for Field Use II-62

Hemispherx Biopharma Acquires DOGS Molecule Patent II-62

Hind Industries to Establish Animal Vaccine Formulations Plant

at Patiala II-62

Cryosite and Animal Health Australia Form Partnership II-62

Hester Pharmaceuticals Plans Capacity Expansion II-62

Biovet to Set up Animal Vaccine Plant in Karnataka II-63

Bogor Institute of Agricultureand Shigeta Establish JV for

Production of CLOSE 5.1 Vaccine II-63

IPB Shigeta Acquires Bird Flu Vaccine Rights from MedImmune II-63

Bioject Medical Technologies Signs Three Agreements WithMerial II-63

PetCARE Television Network signs Distribution Agreement with

Butler Animal Health Supply II-63

Poultry Vaccine to be produced in Vladimir II-64

 

9. FOCUS ON SELECT GLOBAL PLAYERS II-65

Bayer HealthCare AG (Germany) II-65

Biogenesis-Bago (Argentina) II-65

Boehringer Ingelheim GmbH (Germany) II-65

Heska Corporation (US) II-66

Imugene Limited (Australia) II-66

Indian Immunologicals Ltd (India) II-66

Lohmann Animal Health (US) II-67

Merck & Co., Inc. (US) II-67

Merck Animal Health II-68

Merial Ltd. (US) II-68

Pfizer, Inc. (US) II-68

Pfizer Animal Health Global Poultry II-69

Fort Dodge Animal Health (US) II-69

Protein Sciences Corporation (US) II-69

Virbac Corporation (US) II-70

 

10. GLOBAL MARKET PERSPECTIVE II-71

Table 3: World Recent Past, Current & Future Analysis for

Veterinary Vaccines by Geographic Region - US, Europe and Rest

of World Markets Independently Analyzed with Annual Sales

Figures in US$ Million for Years 2009 through 2017 (includes

corresponding Graph/Chart) II-71

 

Table 4: World Historic Review Veterinary Vaccines by

Geographic Region - US, Europe and Rest of World Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2003 through 2008 (includes corresponding

Graph/Chart) II-72

 

Table 5: World 15-Year Perspective for Veterinary Vaccines by

Geographic Region - Percentage Breakdown of Dollar Sales for

US, Europe and Rest of World Markets for Years 2003, 2011 &

2017(includes corresponding Graph/Chart) II-73

 

Table 6: World Recent Past, Current & Future Analysis for

Companion Animal Vaccines by Geographic Region - US, Europe

and Rest of World Markets Independently Analyzed with Annual

Sales Figures in US$ Million for Years 2009 through 2017

(includes corresponding Graph/Chart) II-74

 

Table 7: World Historic Review for Companion Animal Vaccines

by Geographic Region - US, Europe and Rest of World Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2003 through 2008 (includes corresponding

Graph/Chart) II-75

 

Table 8: World 15-Year Perspective for Companion Animal

Vaccines by Geographic Region - Percentage Breakdown of Dollar

Sales for US, Europe and Rest of World Markets for Years 2003,

2011 & 2017 (includes corresponding Graph/Chart) II-76

 

Table 9: World Recent Past, Current & Future Analysis for

Companion Animal Vaccines by Product Segment- Canine Vaccines

& Feline Vaccines Markets Independently Analyzed with Annual

Sales Figures in US$ Million for Years 2009 through 2017

(includes corresponding Graph/Chart) II-77

 

Table 10: World Historic Review for Companion Animal Vaccines

by Product Segment- Canine Vaccines & Feline Vaccines Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2003 through 2008 (includes corresponding

Graph/Chart) II-78

 

Table 11: World 15-Year Perspective for Companion Animal

Vaccines by Product Segment - Percentage Breakdown of Dollar

Sales for Canine Vaccines & Feline Vaccines Markets for Years

2003, 2011 & 2017 (includes corresponding Graph/Chart) II-79

 

Table 12: World Recent Past, Current & Future Analysis for

Canine Vaccines by Geographic Region - US, Europe and Rest of

World Markets Independently Analyzed with Annual Sales Figures

in US$ Million for Years 2009 through 2017 (includes

corresponding Graph/Chart) II-80

 

Table 13: World Historic Review for Canine Vaccines by

Geographic Region - US, Europe and Rest of World Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2003 through 2008 (includes corresponding

Graph/Chart) II-81

 

Table 14: World 15-Year Perspective for Canine Vaccines by

Geographic region - Percentage Breakdown of Dollar Sales for

US, Europe and Rest of World Markets for Years 2003, 2011 &

2017 (includes corresponding Graph/Chart) II-82

 

Table 15: World Recent Past, Current & Future Analysis for

Feline Vaccines by Geographic Region - US, Europe and Rest of

World Markets Independently Analyzed with Annual Sales Figures

in US$ Million for Years 2009 through 2017 (includes

corresponding Graph/Chart) II-83

 

Table 16: World Historic Review for Feline Vaccines by

Geographic Region - US, Europe and Rest of World Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2003 through 2008 (includes corresponding

Graph/Chart) II-84

 

Table 17: World 15-Year Perspective for Feline Vaccines by

Geographic Region - Percentage Breakdown of Dollar Sales for

US, Europe and Rest of World Markets for Years 2003, 2011 &

2017(includes corresponding Graph/Chart) II-85

 

Table 18: World Recent Past, Current & Future Analysis for

Livestock Vaccines by Geographic Region - US, Europe and Rest

of World Markets Independently Analyzed with Annual Sales

Figures in US$ Million for Years 2009 through 2017 (includes

corresponding Graph/Chart) II-86

 

Table 19: World Historic Review for Livestock Vaccines by

Geographic Region - US, Europe and Rest of World Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2003 through 2008 (includes corresponding

Graph/Chart) II-87

 

Table 20: World 15-Year Perspective for Livestock Vaccines by

Geographic Region - Percentage Breakdown of Dollar Sales for

US, Europe and Rest of World Markets for Years 2003, 2011 &

2017 (includes corresponding Graph/Chart) II-88

 

Table 21: World Recent Past, Current & Future Analysis for

Livestock Vaccines by Product Segment - Porcine Vaccines,

Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine

Vaccines and Other Animal Vaccines Markets Independently

Analyzed with Annual Sales Figures in US$ Million for Years

2009 through 2017 (includes corresponding Graph/Chart) II-89

 

Table 22: World Historic Review for Livestock Vaccines by

Product Segment - Porcine Vaccines, Bovine Vaccines, Poultry

Vaccines, Ovine Vaccines, Equine Vaccines & Other Animal

Vaccines Markets Independently Analyzed with Annual Sales

Figures in US$ Million for Years 2003 through 2008 (includes

corresponding Graph/Chart) II-90

 

Table 23: World 15-Year Perspective for Livestock Vaccines by

Product Segment - Percentage Breakdown of Dollar Sales for

Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine

Vaccines, Equine Vaccines & Other Animal Vaccines Markets for

Years 2003, 2011 & 2017 (includes corresponding Graph/Chart) II-91

 

Table 24: World Recent Past, Current & Future Analysis for

Porcine Vaccines by Geographic Region - US, Europe and Rest of

World Markets Independently Analyzed with Annual Sales Figures

in US$ Million for Years 2009 through 2017 (includes

corresponding Graph/Chart) II-92

 

Table 25: World Historic Review for Porcine Vaccines by

Geographic Region - US, Europe and Rest of World Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2003 through 2008 (includes corresponding

Graph/Chart) II-93

 

Table 26: World 15-Year Perspective for Porcine Vaccines by

Geographic Region - Percentage Breakdown of Dollar Sales for

US, Europe and Rest of World Markets for Years 2003, 2011 &

2017 (includes corresponding Graph/Chart) II-94

 

Table 27: World Recent Past, Current and Future Analysis for

Bovine Vaccines by Geographic Region - US, Europe & Rest of

World Markets Independently Analyzed with Annual Sales Figures

in US$ Million for Years 2009 through 2017 (includes

corresponding Graph/Chart) II-95

 

Table 28: World Historic Review for Bovine Vaccines by

Geographic Region - US, Europe and Rest of World Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2003 through 2008 (includes corresponding

Graph/Chart) II-96

 

Table 29: World 15-Year Perspective for Bovine Vaccines by

Geographic region - Percentage Breakdown of Dollar Sales for

US, Europe and Rest of World Markets for Years 2003, 2011 &

2017(includes corresponding Graph/Chart) II-97

 

Table 30: World Recent Past, Current & Future Analysis for

Poultry Vaccines by Geographic Region - US, Europe and Rest of

World Markets Independently Analyzed with Annual Sales Figures

in US$ Million for Years 2009 through 2017 (includes

corresponding Graph/Chart) II-98

 

Table 31: World Historic Review for Poultry Vaccines by

Geographic Region - US, Europe and Rest of World Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2003 through 2008 (includes corresponding

Graph/Chart) II-99

 

Table 32: World 15-Year Perspective for Poultry Vaccines by

Geographic region - Percentage Breakdown of Dollar Sales for

US, Europe and Rest of World Markets for Years 2003, 2011 &

2017 (includes corresponding Graph/Chart) II-100

 

Table 33: World Recent Past, Current & Future Analysis for

Ovine Vaccines by Geographic Region - US, Europe and Rest of

World Markets Independently Analyzed with Annual Sales Figures

in US$ Million for Years 2009 through 2017 (includes

corresponding Graph/Chart) II-101

 

Table 34: World Historic Review for Ovine Vaccines by

Geographic Region - US, Europe and Rest of World Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2003 through 2008 (includes corresponding

Graph/Chart) II-102

 

Table 35: World 15-Year Perspective for Ovine Vaccines by

Geographic region - Percentage Breakdown of Dollar Sales for

US, Europe and Rest of World Markets for Years 2003, 2011 &

2017(includes corresponding Graph/Chart) II-103

 

Table 36: World Recent Past, Current & Future Analysis for

Equine Vaccines by Geographic Region - US, Europe and Rest of

World Markets Independently Analyzed with Annual Sales Figures

in US$ Million for Years 2009 through 2017 (includes

corresponding Graph/Chart) II-104

 

Table 37: World Historic Review for Equine Vaccines by

Geographic Region - US, Europe and Rest of World Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2003 through 2008 (includes corresponding

Graph/Chart) II-105

 

Table 38: World 15-Year Perspective for Equine Vaccines by

Geographic region - Percentage Breakdown of Dollar Sales for

US, Europe and Rest of World Markets for Years 2003, 2011 &

2017 (includes corresponding Graph/Chart) II-106

 

Table 39: World Recent Past, Current & Future Analysis for

Other Animal Vaccines by Geographic Region - US, Europe and

Rest of World Markets Independently Analyzed with Annual Sales

Figures in US$ Million for Years 2009 through 2017 (includes

corresponding Graph/Chart) II-107

 

Table 40: World Historic Review for Other Animal Vaccines by

Geographic Region - US, Europe and Rest of World Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2003 through 2008 (includes corresponding

Graph/Chart) II-108

 

Table 41: World 15-Year Perspective for Other Animal Vaccines

by Geographic region - Percentage Breakdown of Dollar Sales

for US, Europe and Rest of World Markets for Years 2003, 2011

& 2017 (includes corresponding Graph/Chart) II-109

 

III. MARKET

1. THE UNITED STATES III-1

A.Market Analysis III-1

H5N1 Virus: A Conundrum for the US Industry III-1

Rabies Cases in the US III-1

B.Market Analytics III-2

Table 42: US Recent Past, Current & Future Analysis for

Veterinary Vaccines by Product Group/Segment - Companion

Animal Vaccines (Canine Vaccines and Feline Vaccines) and

Livestock Vaccines (Porcine Vaccines, Bovine Vaccines,

Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other

Animal Vaccines) Markets Independently Analyzed with Annual

Sales Figures in US$ Million for Years 2009 through 2017

(includes corresponding Graph/Chart) III-2

 

Table 43: US Historic Review for Veterinary Vaccines by

Product Group/Segment - Companion Animal Vaccines (Canine

Vaccines and Feline Vaccines) and Livestock Vaccines

(Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine

Vaccines, Equine Vaccines and Other Animal Vaccines) Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2003 through 2008 (includes corresponding

Graph/Chart) III-3

 

Table 44: US 15-Year Perspective for Veterinary Vaccines by

Product Group/Segment - Percentage Breakdown of Dollar Sales

for Companion Animal Vaccines (Canine Vaccines and Feline

Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine

Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines

and Other Animal Vaccines) Markets for Years 2003, 2011 &

2017 (includes corresponding Graph/Chart) III-4

 

2. EUROPE III-5

Market Analysis III-5

Table 45: European Recent Past, Current & Future Analysis

for Veterinary Vaccines by Geographic Region - France,

Germany, Italy, UK and Rest of Europe Markets Independently

Analyzed with Annual Sales Figures in US$ Million for Years

2009 through 2017 (includes corresponding Graph/Chart) III-5

 

Table 46: European Historic Review for Veterinary Vaccines

by Geographic Region - France, Germany, Italy, UK and Rest

of Europe Markets Independently Analyzed with Annual Sales

Figures in US$ Million for Years 2003 through 2008 (includes

corresponding Graph/Chart) III-6

 

Table 47: European 15-Year Perspective for Veterinary

Vaccines by Geographic Region - Percentage Breakdown of

Dollar Sales for France, Germany, Italy, UK and Rest of

Europe for Years 2003, 2011 & 2017 (includes corresponding

Graph/Chart) III-7

 

Table 48: European Recent Past, Current & Future for

Veterinary Vaccines by Product Group/Segment - Companion

Animal Vaccines (Canine Vaccines and Feline Vaccines) and

Livestock Vaccines (Porcine Vaccines, Bovine Vaccines,

Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other

Animal Vaccines) Markets Independently Analyzed with Annual

Sales Figures in US$ Million for Years 2009 through 2017

(includes corresponding Graph/Chart) III-8

 

Table 49: European Historic Review for Veterinary Vaccines

by Product Group/Segment - Companion Animal Vaccines (Canine

Vaccines and Feline Vaccines) and Livestock Vaccines

(Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine

Vaccines, Equine Vaccines and Other Animal Vaccines) Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2003 through 2008 (includes corresponding

Graph/Chart) III-9

 

Table 50: European 15-Year Perspective for Veterinary

Vaccines by Product Group/Segment - Percentage Breakdown of

Dollar Sales for Companion Animal Vaccines (Canine Vaccines

and Feline Vaccines) and Livestock Vaccines (Porcine

Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines,

Equine Vaccines and Other Animal Vaccines) Markets for Years

2003, 2011 & 2017(includes corresponding Graph/Chart) III-10

 

2a. FRANCE III-11

Market Analytics III-11

Table 51: French Recent Past, Current & Future Analysis for

Veterinary Vaccines by Product Group/Segment - Companion

Animal Vaccines (Canine Vaccines and Feline Vaccines) and

Livestock Vaccines (Porcine Vaccines, Bovine Vaccines,

Poultry Vaccines, Ovine Vaccines and Equine Vaccines)

Markets Independently Analyzed with Annual Sales Figures in

US$ Million for Years 2009 through 2017 (includes

corresponding Graph/Chart) III-11

 

Table 52: French Historic Review for Veterinary Vaccines by

Product Group/Segment - Companion Animal Vaccines (Canine

Vaccines and Feline Vaccines) and Livestock Vaccines

(Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine

Vaccines, and Equine Vaccines) Markets Independently

Analyzed with Annual Sales Figures in US$ Million for Years

2003 through 2008 (includes corresponding Graph/Chart) III-12

 

Table 53: French 15-Year Perspective for Veterinary Vaccines

by Product Group/Segment - Percentage Breakdown of Dollar

Sales for Companion Animal Vaccines (Canine Vaccines and

Feline Vaccines) and Livestock Vaccines (Porcine Vaccines,

Bovine Vaccines, Poultry Vaccines, Ovine Vaccines and Equine

Vaccines) Markets for Years 2003, 2011 & 2017 (includes

corresponding Graph/Chart) III-13

 

2b. GERMANY III-14

Market Analytics III-14

Table 54: German Recent Past, Current & Future Analysis for

Veterinary Vaccines by Product Group/Segment - Companion

Animal Vaccines (Canine Vaccines and Feline Vaccines) and

Livestock Vaccines (Porcine Vaccines, Bovine Vaccines,

Poultry Vaccines, Ovine Vaccines and Equine Vaccines)

Markets Independently Analyzed with Annual Sales Figures in

US$ Million for Years 2009 through 2017 (includes

corresponding Graph/Chart) III-14

 

Table 55: German Historic Review for Veterinary Vaccines by

Product Group/Segment - Companion Animal Vaccines (Canine

Vaccines and Feline Vaccines) and Livestock Vaccines

(Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine

Vaccines and Equine Vaccines) Markets Independently Analyzed

with Annual Sales Figures in US$ Million for Years 2003

through 2008 (includes corresponding Graph/Chart) III-15

 

Table 56: German 15-Year Perspective for Veterinary Vaccines

by Product Group/ Segment - Percentage Breakdown of Dollar

Sales for Companion Animal Vaccines (Canine Vaccines and

Feline Vaccines) and Livestock Vaccines (Porcine Vaccines,

Bovine Vaccines, Poultry Vaccines, Ovine Vaccines and Equine

Vaccines) Markets for Years 2003, 2011 & 2017 (includes

corresponding Graph/Chart) III-16

 

2c. ITALY III-17

Market Analytics III-17

Table 57: Italian Recent Past, Current & Future Analysis for

Veterinary Vaccines by Product Group/Segment - Companion

Animal Vaccines (Canine Vaccines and Feline Vaccines) and

Livestock Vaccines (Porcine Vaccines, Bovine Vaccines,

Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other

Animal Vaccines) Markets Independently Analyzed with Annual

Sales Figures in US$ Million for Years 2009 through 2017

(includes corresponding Graph/Chart) III-17

 

Table 58: Italian Historic Review for Veterinary Vaccines by

Product Group/Segment - Companion Animal Vaccines (Canine

Vaccines and Feline Vaccines) and Livestock Vaccines

(Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine

Vaccines, Equine Vaccines and Other Animal Vaccines) Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2003 through 2008 (includes corresponding

Graph/Chart) III-18

 

Table 59: Italian 15-Year Perspective for Veterinary

Vaccines by Product Group/Segment - Percentage Breakdown of

Dollar Sales for Companion Animal Vaccines (Canine Vaccines

and Feline Vaccines) and Livestock Vaccines (Porcine

Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines,

Equine Vaccines and Other Animal Vaccines) Markets for Years

2003, 2011 & 2017 (includes corresponding Graph/Chart) III-19

 

2d. THE UNITED KINGDOM III-20

Market Analytics III-20

Table 60: UK Recent Past, Current & Future Analysis for

Veterinary Vaccines by Product Group/Segment - Companion

Animal Vaccines (Canine Vaccines and Feline Vaccines) and

Livestock Vaccines (Porcine Vaccines, Bovine Vaccines,

Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other

Animal Vaccines) Markets Independently Analyzed with Annual

Sales Figures in US$ Million for Years 2009 through 2017

(includes corresponding Graph/Chart) III-20

 

Table 61: UK Historic Review for Veterinary Vaccines by

Product Group/Segment - Companion Animal Vaccines (Canine

Vaccines and Feline Vaccines) and Livestock Vaccines

(Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine

Vaccines, Equine Vaccines and Other Animal Vaccines) Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2003 through 2008 (includes corresponding

Graph/Chart) III-21

 

Table 62: UK 15-Year Perspective for Veterinary Vaccines by

Product Group/Segment - Percentage Breakdown of Dollar Sales

for Companion Animal Vaccines (Canine Vaccines and Feline

Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine

Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines

and Other Animal Vaccines) Markets for Years 2003, 2011 &

2017 (includes corresponding Graph/Chart) III-22

 

2e. REST OF EUROPE III-23

A.Market Analysis III-23

A Note on Danish Veterinary Services III-23

The 2002 Standards of Danish Medicines recommends test for

antibody inducing fragments in veterinary vaccines III-23

Hungary Vaccinates Birds Across Zoos III-24

Russia Mass-Produces Vaccines Against Avian Flu III-24

B.Market Analytics III-25

Table 63: Rest of Europe Recent Past, Current & Future

Analysis for Veterinary Vaccines - by Product Group/ Segment

for Companion Animal Vaccines (Canine Vaccines and Feline

Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine

Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines

and Other Animal Vaccines) Markets Independently Analyzed

with Annual Sales Figures in US$ Million for Years 2009

through 2017 (includes corresponding Graph/Chart) III-25

 

Table 64: Rest of Europe Historic Review for Veterinary

Vaccines by Product Group/Segment - Companion Animal

Vaccines (Canine Vaccines and Feline Vaccines) and Livestock

Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry

Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal

Vaccines) Markets Independently Analyzed with Annual Sales

Figures in US$ Million for Years 2003 through 2008 (includes

corresponding Graph/Chart) III-26

 

Table 65: Rest of Europe 15-Year Perspective for Veterinary

Vaccines by Product/Segment - Percentage Breakdown of Dollar

Sales for Companion Animal Vaccines (Canine Vaccines and

Feline Vaccines) and Livestock Vaccines (Porcine Vaccines,

Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine

Vaccines and Other Animal Vaccines) Markets for Years 2003,

2011 & 2017 (includes corresponding Graph/Chart) III-27

 

3. REST OF WORLD III-28

A.Market Analysis III-28

Focus on Select Regions III-28

Canada III-28

Overview of Canadian Animal Health Industry III-28

Import and Manufacture of Veterinary Biologics III-28

First to Access E. coli 0157:H7 Vaccine III-28

China III-29

A Glance at the Animal Vaccine Market in China III-29

China Initiates Mass Vaccination Campaign Against Bird Flu

Virus III-29

Australia III-30

A Note on Australian Veterinary Therapeutics Market III-30

India III-30

ICAR Develops Indigenous Bird Flu Vaccine III-30

Thailand III-30

Japan & Thailand to Cooperate for Developing Bird Flu Vaccine III-30

Taiwan III-31

Taiwan's Animal Healthcare Industry Under Scan III-31

Malaysia III-31

Malaysia Initiates Measures to Deal with Potential Flu

Pandemic III-31

Kazakhstan III-31

Kazakhstan Takes Proactive Measures Against Bird Flu III-31

North Korea III-31

North Korea Develops Bird Flu Vaccine III-31

Vietnam III-32

Vietnam Imports Bird Flu Vaccines III-32

Egypt III-32

Egypt Reports H5N1 Infection in Vaccinated Flocks III-32

Kenya III-32

Kenya Mass-Manufactures Vaccines Against Rift Valley Fever III-32

B.Market Analytics III-33

Table 66: Rest of World Recent Past, Current & Future

Analysis for Veterinary Vaccines - by Product Group/ Segment

for Companion Animal Vaccines (Canine Vaccines and Feline

Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine

Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines

and Other Animal Vaccines) Markets Independently Analyzed

with Annual Sales Figures in US$ Million for Years 2009

through 2017 (includes corresponding Graph/Chart) III-33

 

Table 67: Rest of World Historic Review for Veterinary

Vaccines by Product Group/Segment - Companion Animal

Vaccines (Canine Vaccines and Feline Vaccines) and Livestock

Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry

Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal

Vaccines) Markets Independently Analyzed with Annual Sales

Figures in US$ Million for Years 2003 through 2008 (includes

corresponding Graph/Chart) III-34

 

Table 68: Rest of World 15-Year Perspective for Veterinary

Vaccines by Product Group/Segment - Percentage Breakdown of

Dollar Sales for Companion Animal Vaccines (Canine Vaccines

and Feline Vaccines) and Livestock Vaccines (Porcine

Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines,

Equine Vaccines and Other Animal Vaccines) Markets for Years

2003, 2011 & 2017 (includes corresponding Graph/Chart) III-35

 

IV. COMPETITIVE LANDSCAPE

Total Companies Profiled: 69 (including Divisions/Subsidiaries - 97)

------------------------------------------

Region/Country Players

------------------------------------------

The United States 30

Canada 5

Japan 3

Europe 28

France 3

Germany 8

The United Kingdom 1

Italy 2

Rest of Europe 14

Asia-Pacific (Excluding Japan) 22

Latin America 5

Africa 1

Middle-East 3

------------------------------------------

To order this report: Drug and Medication Industry: Global Veterinary Vaccines Industry

More Market Research Report

Check our Industry Analysis and Insights

Nicolas Bombourg
Reportlinker
Email: nicolasbombourg@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626


'/>"/>
SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved


Related medicine technology :

1. Global Clinical Diagnostics Automation Industry
2. Global Growth Factors (Blood And Tissue) Industry
3. Global Angiogenesis Inhibitors and Stimulators Industry
4. MarketsandMarkets: Global Healthcare Cloud Computing Market Worth $5,419.8 Million by 2017
5. Global Electrodes for Medical Devices Industry
6. NeuroSigma Receives Global Quality Control Certification
7. MarketsandMarkets: Global Radiotherapy Devices Market Worth $5.8 Billion by 2016
8. Demand for Product Pipeline Review and Analysis Rises in the Global Pharma Industry
9. 3SBio Obtains SFDA Approval to Join Global Phase III Trial for Voclosporin
10. Global Drug-Eluting Stents Industry
11. Global Pain Management Industry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... According to a new market ... Needles, Safety Pen Needles), Needle Length (4mm, 5mm, 6mm, ... of Purchase (Retail, Non-Retail) - Trends & Global Forecasts ... market for the forecast period of 2016 to 2021. ... by 2021 from USD 1.65 Billion in 2016, growing ...
(Date:6/23/2016)... , June 23, 2016 Research ... Devices Global Market - Forecast to 2022" report to ... the treatment method for the patients with kidney failure, it ... excess fluid from the patient,s blood and thus the treatment ... potassium and chloride in balance. Increasing number ...
(Date:6/23/2016)... -- Research and Markets has announced the addition ... - Forecast to 2022" report to their offering. ... to date financial data derived from varied research sources to ... potential impact on the market during the next five years, ... of sub markets, regional and country level analysis. The report ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... ... First Choice Emergency Room , the largest network of independent freestanding ... of its new Mesquite-Samuell Farm facility. , “We are pleased to announce Dr. ... James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , Dr. ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the ... In terms of the latter, setting the bar too high can result in disappointment, ... just slow progress toward their goal. , Research from PsychTests.com reveals ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Marcy was in a crisis. Her son ... lash out at his family verbally and physically. , “When something upset him, he couldn’t ... would use it. He would throw rocks at my other children and say he was ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Comfort Keepers® ... American Cancer Society and the Road To Recovery® program to drive cancer patients to ... and other adults to ensure the highest quality of life and ongoing independence. ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Haute Beauty Network, ... M. Weintraub as a prominent plastic surgeon and the network’s newest partner. ... the most handsome men, look naturally attractive. Plastic surgery should be invisible.” He ...
Breaking Medicine News(10 mins):